Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Development and validation of an instrument to measure the impact of genetic testing on self‐concept in Lynch syndrome

Development and validation of an instrument to measure the impact of genetic testing on... Esplen MJ, Stuckless N, Gallinger S, Aronson M, Rothenmund H, Semotiuk K, Stokes J, Way C, Green J, Butler K, Petersen HV, Wong J. Development and validation of an instrument to measure the impact of genetic testing on self‐concept in Lynch syndrome. A positive genetic test result may impact on a person's self‐concept and affect quality of life. The purpose of the study was to develop a self‐concept scale to measure such impact for individuals carrying mutations for a heritable colorectal cancer Lynch syndrome (LS). Two distinct phases were involved: Phase 1 generated specific colorectal self‐concept candidate scale items from interviews with eight LS carriers and five genetic counselors, which were added to a previously developed self‐concept scale for BRCA1/2 mutation carriers, Phase II had 115 LS carriers complete the candidate scale and a battery of validating measures. A 20‐item scale was developed with two dimensions identified through factor analysis: stigma/vulnerability and bowel symptom‐related anxiety. The scale showed excellent reliability (Cronbach's α = 0.93), good convergent validity by a high correlation with impact of event scale (r(102) = 0.55, p < 0.001) and Rosenberg self‐esteem scale (r(108) = −0.59, p < 0.001), and a low correlation with the Fear questionnaire (r(108) = 0.37, p < 0.001). The scale's performance was stable across participant characteristics. This new scale for measuring self‐concept has potential to be used as a clinical tool and as a measure for future studies. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical Genetics Wiley

Development and validation of an instrument to measure the impact of genetic testing on self‐concept in Lynch syndrome

Download PDF
9 pages

Loading next page...
 
/lp/wiley/development-and-validation-of-an-instrument-to-measure-the-impact-of-tNjLLltre2

References (71)

Publisher
Wiley
Copyright
© 2011 John Wiley & Sons A/S
ISSN
0009-9163
eISSN
1399-0004
DOI
10.1111/j.1399-0004.2011.01770.x
pmid
21883167
Publisher site
See Article on Publisher Site

Abstract

Esplen MJ, Stuckless N, Gallinger S, Aronson M, Rothenmund H, Semotiuk K, Stokes J, Way C, Green J, Butler K, Petersen HV, Wong J. Development and validation of an instrument to measure the impact of genetic testing on self‐concept in Lynch syndrome. A positive genetic test result may impact on a person's self‐concept and affect quality of life. The purpose of the study was to develop a self‐concept scale to measure such impact for individuals carrying mutations for a heritable colorectal cancer Lynch syndrome (LS). Two distinct phases were involved: Phase 1 generated specific colorectal self‐concept candidate scale items from interviews with eight LS carriers and five genetic counselors, which were added to a previously developed self‐concept scale for BRCA1/2 mutation carriers, Phase II had 115 LS carriers complete the candidate scale and a battery of validating measures. A 20‐item scale was developed with two dimensions identified through factor analysis: stigma/vulnerability and bowel symptom‐related anxiety. The scale showed excellent reliability (Cronbach's α = 0.93), good convergent validity by a high correlation with impact of event scale (r(102) = 0.55, p < 0.001) and Rosenberg self‐esteem scale (r(108) = −0.59, p < 0.001), and a low correlation with the Fear questionnaire (r(108) = 0.37, p < 0.001). The scale's performance was stable across participant characteristics. This new scale for measuring self‐concept has potential to be used as a clinical tool and as a measure for future studies.

Journal

Clinical Genetics – Wiley

Published: Nov 1, 2011

There are no references for this article.